Exciting Innovations at Profound Medical's Investor Event
Profound Medical Corp. (NASDAQ: PROF; TSX: PRN), a leader in advancing medical device technology, will host an engaging investor event on the horizon. This hybrid event, merging in-person attendance with a virtual experience, is set against the backdrop of the American Urological Association (AUA) Annual Meeting. Attendees can expect insightful presentations and discussions that will shed light on groundbreaking developments in incision-free therapies.
Event Details
This much-anticipated agenda takes place in Las Vegas, offering an opportunity for both investors and healthcare professionals to connect with the company’s management team. Kicking off at 3:30 PM Pacific Time and concluding at approximately 5:00 PM, the program promises a comprehensive overview of the latest innovations in urology.
Overview and Welcome
The event will begin with a welcome address from Dr. Mathieu Burtnyk, who serves as the President of Profound Medical. He will introduce the session with exciting peri-operative results from the Level 1 CAPTAIN study, which compares the TULSA procedure to traditional radical prostatectomy in patients with localized prostate cancer.
Expert Insights
Following Dr. Burtnyk’s introduction, Dr. Ram A. Pathak, an Associate Professor of Urology, will share his valuable insights regarding the TULSA-PRO technology. His focus will be on optimizing workflows and examining clinical outcome data, reinforcing the efficacy of this innovative approach to prostate treatment.
Corporate Highlights
CEO Arun Menawat will delve deeper into two significant programs slated for 2025. The first is the TULSA-AI module, designed to enhance treatment for benign prostatic hyperplasia (BPH), featuring a live demonstration of the technology. Next, he'll discuss the TULSA+ program, an amalgamation of the TULSA-PRO system with advanced interventional MRI technology from Siemens Healthineers.
Future Perspectives
Expert doctor Naveen Kella will speak on the TULSA procedure's capability to effectively handle BPH, sharing perspectives on current and future approaches. This highlights both the method's potential and its applications in clinical contexts.
Commercial Insights
Finally, Chief Commercial Officer Tom Tamberrino will present the business model associated with the TULSA+ program, covering its commercial plans and targeted benefits, rounding out the informative agenda.
Your Opportunity to Engage
Attendees wishing to join this unique experience on-site must register in advance through the specified link. Additionally, those who cannot attend in person will have access to a live-streamed version of the event, enabling them to gain insights remotely through the company’s website.
About Profound Medical Corp.
Profound Medical is at the forefront of revolutionizing surgical treatment modalities. Known for its customizable, incision-free therapies, the company's flagship TULSA-PRO technology utilizes real-time MRI along with ultrasound capabilities. This ensures precision in targeting prostate tissue while preserving essential functions like urinary continence and sexual health. By adhering to a non-invasive method, patients benefit from significantly less downtime, with many returning to regular activities shortly after.
In addition to TULSA-PRO, Profound also offers the Sonalleve platform, aimed at treating uterine fibroids and managing pain from bone metastases. This innovative solution has captured attention worldwide, backed by regulatory approvals from health authorities, ensuring patients receive the highest standard of care.
Frequently Asked Questions
What is the main focus of Profound Medical's upcoming investor event?
The event aims to showcase innovative developments in incision-free therapies, especially concerning the TULSA procedure and upcoming technologies.
Who will be speaking at the event?
Key speakers include Dr. Mathieu Burtnyk, Dr. Ram A. Pathak, CEO Arun Menawat, Dr. Naveen Kella, and Chief Commercial Officer Tom Tamberrino.
How can I register for the in-person event?
Advance registration for the event is required; details are available through the company’s designated link.
Will the event be available for online viewing?
Yes, there will be a live webcast available for remote attendees, as well as an archived version for later viewing.
What advancements is Profound Medical focused on?
Profound is concentrating on incision-free treatment solutions, particularly through the TULSA-PRO system and exploring new markets for its Sonalleve platform.
